- Pioro EP, Antel JP, Cashman NR, Arnold DL Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994; 44; 1933-1938.
- Jones AP, Gunawardena WJ, Coutinho CMA, Gatt JA, Shaw IC, Mitchell JD. Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amyotrophic lateral sclerosis). J Neurol Sci 1995; 129: 85-89.
- Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin M. Quantification of brain metabolites in amyotrophic lateral sclerosis by localised proton magnetic resonance spectroscopy. Neurology 1997; 48: 878-881.
- Rooney W, Miller RD, Gelinas D et al. Decreased N-acetyl aspartate in motor cortex and corticospinal tract in ALS. Neurology 1998; 50: 1800-1805.
- Block W, Karitzsky J, Traber F et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease. Arch Neurol 1998; 55: 931-936.
- Pan JW, Hoby P, Hetherington J et al. Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T. Magn Reson Med 1996; 36: 72-77.
- Eazareff JA, Olmstead C, Bockhorst KH, Alger JR. Proton magnetic resonance spectroscopic imaging of paediatric lowgrade astrocytomas. Childs Nerv Syst 1996; 12: 130-135.
- De Stefano N, Matthews PM, Arnold DL Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995; 34: 721-727.
- Kalra S, Cashman NR, Genge A, Arnold DL Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. NeuroReport 1998; 9: 1757-1761.
- Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SCR, Leigh PN. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 1998; 51: 1104-1109.
- Brooks BR. World Federation of Neurology Research Group on NeuiOinuscular Disorders. J Neurol Sci 1994; 124: 96-107.
- Hillel AD, Miller RD, Yorkston K, McDonald E, Norris FH, Konikao N. Amyotrophic lateral sclerosis severity scale. Neuroepidemiology 1989; 8: 142-150.
- Vion-Duiy J, Meyerhoff DJ, Cozzone PJ, Weiner MW. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J Neurol 1994; 241: 354-371.
- Howe FA, Maxwell RJ, Saunders DE, Brown MM, Griffiths JR. Proton spectroscopy in vivo. Magn Reson Q 1993; 9: 31-59.
- Simmons A, Smail M, Moore E, Williams SCR. Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain. Magn Reson Imaging 1998; 16: 319-330.
- Taylor DE, Davies SEC, Obrenovitch TP et al. Extracellular N-acetyl aspartate in the brain: in vivo determination of basal levels and changes evoked by high K+. J Neurochem 1994; 62: 2349-2355.
- Tallan HH. Studies on the distribution of N-acetyl-E-aspartic acid in brain. J Biol Chem 1957; 224: 41-45.
- Miyake M, Kakimoto Y, Sorimachi M. A gas Chromatographic method for the determination of N-acetyl-L-aspartic acid, N-acetyl-a-aspartylglutamic acid and a-citryl-L-glutamic acid and their distributions in the brain and other organs of various species of animals. J Neurochem 1981; 36: 804-810.
- Whittingham TS, Douglas A, Holtzman D. Creatine and nucleotide triphosphates in rat cerebral grey and white matter. Metab Brain Dis 1995; 10: 347-352.
- Erecinska M, Silver IA. ATP and brain function. J Cereb Blood Flow Metab 1989; 9: 2-19.
- Pouwels PJW, Frahm J. Regional metabolite concentrations as determined by quantitative localised proton MRS. Magn Reson Med 1998; 39: 53-60.
- Sober BJ, van Zigl PCM, Duyn JH, Barker PN. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996; 35: 356-363.
- Doyle TJ, Bedell BJ, Narayana PA. Relative concentrations of proton MR visible neurochemicals in grey and white matter in human brain. Magn Reson Med 1995; 33: 755-759.
- Wang Y, Li SJ. Differentiation of metabolite concentrations between grey matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy. Magn Res Med 1998; 39: 28-33.
- Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13: 981-989.
- Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 1994; 44: 1411-1417.
- Chang L, Ernst T, Osborn D, Seltzer W, Leonido-Yee M, Poland RE. Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats. Arch Neurol 1998; 55: 305-311.
- Chang L, Ernst T, Tornatore C et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 1997; 48: 836-845.
- Kushner PD, Stephensen DT, Wright S. Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain. J Neuropathol Exp Neurol 1991; 50: 263-277.
- Brown P. Pathophysiology of spasticity. J Neurol Neurosurg Psychiatiy 1994; 57: 773-777.
- Travis AM. Neurological deficiencies after ablation of the precentral motor area in Macaca mulatta. Brain 1955; 78: 155-173.
- Gilman S, Marco EA, Ebel HC. Effects of medullary pyramidotomy in the monkey. 11. Abnormalities of spindle afferent responses. Brain 1973; 94: 515-530.
- Cannon BW, Beaton EE, Ranson SW. Nature of paresis following lateral corticospinal section in monkeys. J Neurophysiol 1943; 6: 425-430.
- Davie CA, Hawkins CP, Barker GJ et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117: 49-58.
- Clarke DD, Greenfield S, Dicker E, Tirri EJ, Ronan EJ. A relationship of N-acetylaspartate biosynthesis to neuronal protein synthesis. J Neurochem 1975; 24: 479-485.
- Cangro CB, Namboodiri MA, Sklar EA, Corigliano-Murphy A, Neale JH. Immunohistochemistry and biosynthesis of N-acetylaspartylglutamate in spinal sensory ganglia. J Neurochem 1987; 49: 1579-1588.
- Lee JH, Arcinue E, Ross BD. Brief report: organic osmolytes in the brain of an infant with hypernatraemia. N Engl J Med 1994; 331: 439-442.
- Truckenmiller ME, Namboodiri MA, Brownstein MJ, Neale JH. N-acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme. J Neurochem 1985; 45: 1658-1662.
- Clark JB. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 1998; 20: 271-276.
- Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing a wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995; 676: 25-40.
- Kong J, Zuoshang X. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SODl. J Neurosci 1998; 18: 3241-3250.
- Sasaki S, Iwata M. Ultrastructural study of synapses in the anterior horn cells of patients with amyotrophic lateral sclerosis. Neurosci Lett 1996; 204: 53-56.
- Comi GP, Bordoni A, Salani S et al. Cytochrome c oxidase subunit 1 microdeletion in a patient with motor neuron disease. Ann Neurol 1998; 43: 110-116.
- Kuzniecky R, Hetherington H, Pan J et al. Proton spectroscopic imaging at 4.1 Tesla in patients with malformations of cortical development and epilepsy. Neurology 1997; 48: 1018-1024.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
Volume 1, 2000 - Issue 2